Effects of first- and second-generation tyrosine kinase inhibitor therapy on glucose and lipid metabolism in chronic myeloid leukemia patients: a real clinical problem?

Effects of first- and second-generation tyrosine kinase inhibitor therapy on glucose and lipid metabolism in chronic myeloid leukemia patients: a real clinical problem? — المؤلف: Iurlo, Alessandra — Oncotarget 20160822

المؤلف
Iurlo, Alessandra
النشر
Oncotarget 20160822
الوصف
33944-51 p.
الموضوعات
Adult؛ Aged؛ Aged, 80 and over؛ Anthropometry؛ Blood Glucose؛ C-Peptide؛ Cohort Studies؛ Dasatinib